About David Gregorka
David Gregorka is a director at Genomenon.
Form D filings also name David Gregorka as a director at Neochord and a secty, treasurer at Kumanu.
David Gregorka first appears on SEC filings in 2016.
Experience
This experience comes from David Gregorka's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Gregorka in the role, so the role may have started earlier or lasted longer.
Genomenon, Inc. Current
Director
2018 – Present · Ann Arbor, MI
Genomenon sells genetic evidence software and services to clinical labs and drug developers.
UP
University of Michigan Innovation Partnerships Current
Mentor-In-Residence (Emeritus-January 2024)
2013 – Present
AL
A2B2 Associates, LLC
Principal
2013 – 2024
BC
Baird Capital
Venture Partner
2013 – 2024
UI
University of Michigan Weil Institute
Chair, External Advisory Board
2019 – 2022
UC
University of Michigan MTRAC for Life Sciences Oversight Committee
Oversight Committee Member
2013 – 2022
KL
Kinetica Labs
Board Member
2020 – 2021
SO
Strata Oncology
Board of Directors (Observer)
2016 – 2021
IM
Invest Michigan
Board Member
2014 – 2021
UB
University of Michigan, Michigan Biomedical Venture Fund Investment Advisory Board
Board Member
2016 – 2020
NI
NeuMoDx Molecular, Inc.
Board of Directors (Observer)
2014 – 2020
MB
MI Bioresearch
Board of Directors (Observer)
2013 – 2019
PA
Parabricks
President
2018
II
Ideomed, Inc.
Advisory Board Member
2014
CU
CureLauncher
Advisory Board Member
2013 – 2014
HI
HealthMedia, Inc.
Vice President, Operations (HealthMedia)
1998 – 2008
CC
Consortium for International Earth Science Information Network (CIESIN)
VP, Finance and Administration
1991 – 1998
NI
NSF International
Vice President, Administration
1981 – 1991
Key Colleagues at Startups
The people David Gregorka works with at each company, as listed on that company's latest Form D.
Genomenon, Inc. · Form D, Jul 30, 2026
Sam Globus
Chief Operating Officer
MG
Michael Gross
Director
Michael Klein
Chief Executive Officer and director
Mark Kiel
Chief Scientific Officer & Co-Founder, director
PG
Patricia Glaza
Director
Brian Groark
Chief Financial Officer
Neochord Inc. · Form D, Jul 5, 2023
DN
David Neustaedter
Director
RN
Ron Nelson
CFO
JM
J. Martin
Director
DC
David Chung
Executive officer and director
Mudit Jain
Director
CT
Casey Tansey
Director
Kumanu, Inc. · Form D, Sep 7, 2017
YB
Young Bang
Director
JB
Jeffrey Bistrong
Director
RC
Robert Carr
Director
VS
Victor Strecher
Executive officer and director